Gary Morrow: Clinical Trials

16 trials sponsored by Gary Morrow, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 1 terminated. 7 Phase 3, 6 Not applicable, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 6, Terminated 1
Not applicable6Completed 6
Phase 24Completed 4

Follow Gary Morrow: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Curcumin-based Gel, Dermatologic Complications Management, Laboratory Biomarker Analysis - Breast Carcinoma, Pain
Phase 2CompletedGary Morrow1912015-10-132017-11-06
Omega-3 Fatty Acid in Reducing Cancer-Related Fatigue in Breast Cancer Survivors
Omega-3 Fatty Acid, Placebo, Questionnaire Administration - Breast Carcinoma, Cancer
Not applicableCompletedGary Morrow1082015-02-012017-08-08
Multimedia Psychoeducation or Print Education in Preparing Cancer Patients for Decision Making About Clinical Trials
print educational intervention, multimedia psychoeducational intervention - Malignant Neoplasm
Not applicableCompletedGary Morrow4182014-05-012021-01-27
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy
Brief Behavioral Therapy, Telephone-Based Intervention, Educational Intervention - Sleep Disorder, Stage IA Breast Cancer
Not applicableCompletedGary Morrow712014-02-032019-06-05
Exercise in Lessening Fatigue Caused by Cancer in Patients Undergoing Chemotherapy
exercise - Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
Not applicableCompletedGary Morrow6932009-09-012017-08-08
Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
naproxen, placebo - Musculoskeletal Complications, Pain
Phase 3CompletedGary Morrow5102008-06-012015-11-09
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
ketamine/amitriptyline NP-H cream, placebo - Neurotoxicity, Pain
Phase 3CompletedGary Morrow4622007-10-012015-11-09
Yoga in Treating Sleep Disturbance in Cancer Survivors
Standard Care Control Condition, Yoga Intervention (YOCAS) - Fatigue, Cancer
Phase 2CompletedGary Morrow4102006-10-012017-02-20
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
ginger, placebo - Nausea, Vomiting
Phase 2 / Phase 3CompletedGary Morrow7452003-03-012015-11-09
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
dalteparin, gemcitabine hydrochloride, quality-of-life assessment - Pancreatic Cancer, Thromboembolism
Phase 3TerminatedGary Morrow4002002-10-012015-10-14
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
modafinil - Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
Phase 3CompletedGary Morrow8372002-08-012015-10-15
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
dolasetron mesylate, granisetron hydrochloride, ondansetron - Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
Phase 3CompletedGary Morrow2001-07-012015-10-15
Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
gabapentin, quality-of-life assessment - Anxiety Disorder, Breast Cancer
Not applicableCompletedGary Morrow2001-07-012015-10-15
Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
dolasetron mesylate, granisetron hydrochloride, ondansetron - Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
Phase 2CompletedGary Morrow7001999-10-012015-10-15
Group Therapy Compared With Educational Materials in Patients With Prostate Cancer
psychosocial assessment and care, quality-of-life assessment - Prostate Cancer, Psychosocial Effects of Cancer and Its Treatment
Not applicableCompletedGary Morrow4801997-04-012013-03-05
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
ciprofloxacin, ofloxacin, 160 mg trimethoprim and 800 mg sulfamethoxazole - Infection, Multiple Myeloma
Phase 3CompletedGary Morrow2121997-03-012015-11-11

Conditions studied

Breast Neoplasms (4)  ·  Fatigue (4)  ·  Nausea (3)  ·  Neoplasms (3)  ·  Pain (3)  ·  Vomiting (3)  ·  Sleep Wake Disorders (2)  ·  Anxiety Disorders (1)  ·  Breast Carcinoma In Situ (1)  ·  Depression (1)  ·  Hot Flashes (1)  ·  Infections (1)  ·  Multiple Myeloma (1)  ·  Neurotoxicity Syndromes (1)  ·  Pancreatic Neoplasms (1)

Interventions

Granisetron (2)  ·  Methods (2)  ·  Ondansetron (2)  ·  dolasetron (2)  ·  Behavior Therapy (1)  ·  Ciprofloxacin (1)  ·  Curcumin (1)  ·  Dalteparin (1)  ·  Docosahexaenoic Acids (1)  ·  Early Intervention, Educational (1)  ·  Educational Status (1)  ·  Exercise (1)  ·  Fatty Acids, Omega-3 (1)  ·  Gabapentin (1)  ·  Gemcitabine (1)

Countries

United States (16)  ·  Peru (1)  ·  South Africa (1)

Top investigators

Gary R. Morrow, PhD, MS (6)  ·  Karen M. Mustian, PhD (2)  ·  Kishan J. Pandya, MD (2)  ·  Claire Pomeroy, MD (1)  ·  Jeffrey J. Kirshner, MD (1)  ·  Jeffrey K. Giguere, MD, FACP (1)  ·  Julie L. Ryan, PhD, MPH (1)  ·  Luke Peppone (1)  ·  Martin M. Oken, MD (1)  ·  Oxana Palesh (1)  ·  Paul Jacobsen (1)  ·  Supriya Mohile, MD (1)

Results publications

PMID 12906958, PMID 16139656, PMID 16198982, PMID 20564068, PMID 23940231, PMID 24531792, PMID 29243164, PMID 30937600, PMID 31165647, PMID 32812824, PMID 34191201, PMID 35416182, PMID 39368335, PMID 40421669, PMID 41170811, PMID 41825129

NIH funding

U10CA037420 (10), UG1CA189961 (3), R03CA175599 (1), R21CA178648 (1)